Literature DB >> 27152136

Effect of Roux-en-Y gastric bypass surgery on intestinal Akkermansia muciniphila.

Ming Yan1, Mao-Min Song1, Ri-Xing Bai1, Shi Cheng1, Wen-Mao Yan1.   

Abstract

AIM: To investigated changes in intestinal Akkermansia muciniphila (A. muciniphila) and explored the mechanism underlying the therapeutic effects of Roux-en-Y gastric bypass (RYGB) surgery on type 2 diabetes in diabetic Goto-Kakizaki (GK) rats.
METHODS: Male diabetic GK rats (n = 12) aged 8 wk were randomly assigned to the surgery group (GK-RYGB) or sham surgery group (GK-Sham) (n = 6 per group), and another 6 male Wistar rats aged 8 wk served as controls (WS-Sham). In the surgery group, RYGB surgery was conducted, and a sham operation was performed in both sham groups. Fasting blood glucose (FBG) levels before and after surgery, fasting levels of serum insulin and serum glucagon-like peptide-1 (GLP-1) and levels 30 min after intragastric injection of glucose, and the amount of A. muciniphila in the stool were determined. Insulin and GLP-1 were measured by enzyme-linked immunosorbent assay, and A. muciniphila were detected by fluorescence-based quantitative polymerase chain reaction.
RESULTS: The FBG was improved, and serum GLP-1 and insulin increased significantly (P < 0.05) in the GK-RYGB group after surgery compared to levels before surgery and to levels in the GK-Sham group. Before surgery, the amounts of A. muciniphila in the GK-RYGB and GK-Sham groups were significantly lower than in the WS-Sham group (P < 0.05). After surgery, the amount of A. muciniphila in the GK-RYGB group increased markedly compared to that before surgery and to that in the GK-Sham and WS-Sham groups (P < 0.05). In addition, the A. muciniphila amount was positively related to GLP-1 (r = 0.86, P < 0.05).
CONCLUSION: Our results demonstrated RYGB surgery may increase GLP-1 secretion, elevate serum insulin after intragastric injection of glucose, and improve insulin resistance in diabetic GK rats, thereby contributing to a significant reduction in blood glucose. The increased amount of A. muciniphila after RYGB surgery may be related to elevated GLP-1 secretion.

Entities:  

Keywords:  Akkermansia mucinipilia; Glucagon-like peptide-1; Glucose-dependent insulinotropic peptide; Roux-en-Y gastric bypass surgery; Type 2 diabetes

Year:  2016        PMID: 27152136      PMCID: PMC4840169          DOI: 10.4240/wjgs.v8.i4.301

Source DB:  PubMed          Journal:  World J Gastrointest Surg


  31 in total

1.  Ileal interposition surgery improves glucose and lipid metabolism and delays diabetes onset in the UCD-T2DM rat.

Authors:  Bethany P Cummings; April D Strader; Kimber L Stanhope; James L Graham; Jennifer Lee; Helen E Raybould; Denis G Baskin; Peter J Havel
Journal:  Gastroenterology       Date:  2010-03-10       Impact factor: 22.682

2.  The gut microbiota as an environmental factor that regulates fat storage.

Authors:  Fredrik Bäckhed; Hao Ding; Ting Wang; Lora V Hooper; Gou Young Koh; Andras Nagy; Clay F Semenkovich; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-25       Impact factor: 11.205

3.  2-Oleoyl glycerol is a GPR119 agonist and signals GLP-1 release in humans.

Authors:  Katrine B Hansen; Mette M Rosenkilde; Filip K Knop; Niels Wellner; Thi A Diep; Jens F Rehfeld; Ulrik B Andersen; Jens J Holst; Harald S Hansen
Journal:  J Clin Endocrinol Metab       Date:  2011-07-21       Impact factor: 5.958

Review 4.  Current status of medical and surgical therapy for obesity.

Authors:  E C Mun; G L Blackburn; J B Matthews
Journal:  Gastroenterology       Date:  2001-02       Impact factor: 22.682

5.  Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease.

Authors:  Francesco Rubino; Jacques Marescaux
Journal:  Ann Surg       Date:  2004-01       Impact factor: 12.969

6.  Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults.

Authors:  Nadja Larsen; Finn K Vogensen; Frans W J van den Berg; Dennis Sandris Nielsen; Anne Sofie Andreasen; Bente K Pedersen; Waleed Abu Al-Soud; Søren J Sørensen; Lars H Hansen; Mogens Jakobsen
Journal:  PLoS One       Date:  2010-02-05       Impact factor: 3.240

7.  Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers.

Authors:  Jean-Pierre Furet; Ling-Chun Kong; Julien Tap; Christine Poitou; Arnaud Basdevant; Jean-Luc Bouillot; Denis Mariat; Gérard Corthier; Joël Doré; Corneliu Henegar; Salwa Rizkalla; Karine Clément
Journal:  Diabetes       Date:  2010-09-28       Impact factor: 9.461

8.  Richness of human gut microbiome correlates with metabolic markers.

Authors:  Emmanuelle Le Chatelier; Trine Nielsen; Junjie Qin; Edi Prifti; Falk Hildebrand; Gwen Falony; Mathieu Almeida; Manimozhiyan Arumugam; Jean-Michel Batto; Sean Kennedy; Pierre Leonard; Junhua Li; Kristoffer Burgdorf; Niels Grarup; Torben Jørgensen; Ivan Brandslund; Henrik Bjørn Nielsen; Agnieszka S Juncker; Marcelo Bertalan; Florence Levenez; Nicolas Pons; Simon Rasmussen; Shinichi Sunagawa; Julien Tap; Sebastian Tims; Erwin G Zoetendal; Søren Brunak; Karine Clément; Joël Doré; Michiel Kleerebezem; Karsten Kristiansen; Pierre Renault; Thomas Sicheritz-Ponten; Willem M de Vos; Jean-Daniel Zucker; Jeroen Raes; Torben Hansen; Peer Bork; Jun Wang; S Dusko Ehrlich; Oluf Pedersen
Journal:  Nature       Date:  2013-08-29       Impact factor: 49.962

9.  Gastric bypass leads to improvement of diabetic neuropathy independent of glucose normalization--results of a prospective cohort study (DiaSurg 1 study).

Authors:  Beat P Müller-Stich; Lars Fischer; Hannes G Kenngott; Matthias Gondan; Jonas Senft; Gabriella Clemens; Felix Nickel; Thomas Fleming; Peter P Nawroth; Markus W Büchler
Journal:  Ann Surg       Date:  2013-11       Impact factor: 12.969

10.  Innate immunity and intestinal microbiota in the development of Type 1 diabetes.

Authors:  Li Wen; Ruth E Ley; Pavel Yu Volchkov; Peter B Stranges; Lia Avanesyan; Austin C Stonebraker; Changyun Hu; F Susan Wong; Gregory L Szot; Jeffrey A Bluestone; Jeffrey I Gordon; Alexander V Chervonsky
Journal:  Nature       Date:  2008-09-21       Impact factor: 49.962

View more
  10 in total

Review 1.  Microbiome, bile acids, and obesity: How microbially modified metabolites shape anti-tumor immunity.

Authors:  Laura M Sipe; Mehdi Chaib; Ajeeth K Pingili; Joseph F Pierre; Liza Makowski
Journal:  Immunol Rev       Date:  2020-05       Impact factor: 12.988

Review 2.  The Gut Microbiota: The Gateway to Improved Metabolism.

Authors:  Kristina B Martinez; Joseph F Pierre; Eugene B Chang
Journal:  Gastroenterol Clin North Am       Date:  2016-12       Impact factor: 3.806

Review 3.  Mechanisms of weight loss and improved metabolism following bariatric surgery.

Authors:  Christopher M Mulla; Roeland J W Middelbeek; Mary-Elizabeth Patti
Journal:  Ann N Y Acad Sci       Date:  2017-09-03       Impact factor: 5.691

4.  Gut microbiome differences between metformin- and liraglutide-treated T2DM subjects.

Authors:  Zhang Wang; Somdutta Saha; Stephanie Van Horn; Elizabeth Thomas; Christopher Traini; Ganesh Sathe; Deepak K Rajpal; James R Brown
Journal:  Endocrinol Diabetes Metab       Date:  2017-12-28

Review 5.  Metabolically Healthy Obesity-Heterogeneity in Definitions and Unconventional Factors.

Authors:  Inês Brandão; Maria João Martins; Rosário Monteiro
Journal:  Metabolites       Date:  2020-01-27

6.  Ileal microbial shifts after Roux-en-Y gastric bypass orchestrate changes in glucose metabolism through modulation of bile acids and L-cell adaptation.

Authors:  Jerry T Dang; Valentin Mocanu; Heekuk Park; Michael Laffin; Caroline Tran; Naomi Hotte; Shahzeer Karmali; Daniel W Birch; Karen Madsen
Journal:  Sci Rep       Date:  2021-12-10       Impact factor: 4.379

Review 7.  Gut Microbiota: An Important Player in Type 2 Diabetes Mellitus.

Authors:  Zheng Zhou; Bao Sun; Dongsheng Yu; Chunsheng Zhu
Journal:  Front Cell Infect Microbiol       Date:  2022-02-15       Impact factor: 5.293

8.  Akkermansia muciniphila May Determine Chondroitin Sulfate Ameliorating or Aggravating Osteoarthritis.

Authors:  Qi Wang; Shui-Qing Huang; Chang-Qing Li; Qin Xu; Qing-Ping Zeng
Journal:  Front Microbiol       Date:  2017-10-09       Impact factor: 5.640

9.  Alpinia oxyphylla Miq. Extract Prevents Diabetes in Mice by Modulating Gut Microbiota.

Authors:  Yiqiang Xie; Man Xiao; Yali Ni; Shangfei Jiang; Guizhu Feng; Shenggang Sang; Guankui Du
Journal:  J Diabetes Res       Date:  2018-06-04       Impact factor: 4.011

Review 10.  Neurohormonal Changes in the Gut-Brain Axis and Underlying Neuroendocrine Mechanisms following Bariatric Surgery.

Authors:  Eirini Martinou; Irena Stefanova; Evangelia Iosif; Angeliki M Angelidi
Journal:  Int J Mol Sci       Date:  2022-03-19       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.